Furthering the Prostate Cancer Screening Debate (Prostate Cancer Specific Mortality and Associated Risks) (Review) Furthering the Prostate Cancer Screening Debate (Prostate Cancer Specific Mortality and Associated Risks) (Review)

Furthering the Prostate Cancer Screening Debate (Prostate Cancer Specific Mortality and Associated Risks) (Review‪)‬

Canadian Urological Association Journal (CUAJ) 2011, Dec 1, 5, 6

Canadian Urological Association Journal (CUAJ)
    • $5.99
    • $5.99

Publisher Description

Author(s): G. Michael Allan, MD, CCFP, Michael P. Chetner, MD, MSc, FRCSC, FACS, Bryan J. Donnelly, MCh, MSc, FRCSC, Neil A. Hagen, MD, FRCPC, David Ross, MD, CCFP, J. Dean Ruether, MD, FRCPC, Peter Venner, MD Introduction

GENRE
Health, Mind & Body
RELEASED
2011
December 1
LANGUAGE
EN
English
LENGTH
19
Pages
PUBLISHER
Canadian Urological Association
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
228.1
KB

More Books Like This

Assessing the Clinical Impact of Prostate-Specific Antigen Assay Variability and Nonequimolarity: A Simulation Study Based on the Population of the United Kingdom (Cancer Diagnostics) Assessing the Clinical Impact of Prostate-Specific Antigen Assay Variability and Nonequimolarity: A Simulation Study Based on the Population of the United Kingdom (Cancer Diagnostics)
Assessing the Clinical Impact of Prostate-Specific Antigen Assay Variability and Nonequimolarity: A Simulation Study Based on the Population of the United Kingdom (Cancer Diagnostics)
2004
SELDI-TOF MS Whole Serum Proteomic Profiling with IMAC Surface Does Not Reliably Detect Prostate Cancer (Proteomics and Protein Markers) (Clinical Report) SELDI-TOF MS Whole Serum Proteomic Profiling with IMAC Surface Does Not Reliably Detect Prostate Cancer (Proteomics and Protein Markers) (Clinical Report)
SELDI-TOF MS Whole Serum Proteomic Profiling with IMAC Surface Does Not Reliably Detect Prostate Cancer (Proteomics and Protein Markers) (Clinical Report)
2008
Comparison of Logistic Regression and Neural Net Modeling for Prediction of Prostate Cancer Pathologic Stage (Oak Ridge Conference) Comparison of Logistic Regression and Neural Net Modeling for Prediction of Prostate Cancer Pathologic Stage (Oak Ridge Conference)
Comparison of Logistic Regression and Neural Net Modeling for Prediction of Prostate Cancer Pathologic Stage (Oak Ridge Conference)
2002
Cancer and Elders of Color: Opportunities for Reducing Health Disparities Cancer and Elders of Color: Opportunities for Reducing Health Disparities
Cancer and Elders of Color: Opportunities for Reducing Health Disparities
2019
Design and Analysis of Clinical Trials Design and Analysis of Clinical Trials
Design and Analysis of Clinical Trials
2013
Cancer Risk Cancer Risk
Cancer Risk
2019

More Books by Canadian Urological Association Journal (CUAJ)

Diagnosis of Interstitial Cystitis June 2007 (CUA Guidelines) (Report) Diagnosis of Interstitial Cystitis June 2007 (CUA Guidelines) (Report)
Diagnosis of Interstitial Cystitis June 2007 (CUA Guidelines) (Report)
2009
Physical Activity and Quality of Life After Radical Prostatectomy (Original Research) (Clinical Report) Physical Activity and Quality of Life After Radical Prostatectomy (Original Research) (Clinical Report)
Physical Activity and Quality of Life After Radical Prostatectomy (Original Research) (Clinical Report)
2010
Childhood Sexual Trauma in Women with Interstitial Cystitis/Bladder Pain Syndrome: A Case Control Study (Original Research) (Report) Childhood Sexual Trauma in Women with Interstitial Cystitis/Bladder Pain Syndrome: A Case Control Study (Original Research) (Report)
Childhood Sexual Trauma in Women with Interstitial Cystitis/Bladder Pain Syndrome: A Case Control Study (Original Research) (Report)
2011
The Status of Pelvic Floor Muscle Training for Women (Review) (Report) The Status of Pelvic Floor Muscle Training for Women (Review) (Report)
The Status of Pelvic Floor Muscle Training for Women (Review) (Report)
2010
Chemoprevention in Bladder Cancer: What's New?(Review) (Disease/Disorder Overview) Chemoprevention in Bladder Cancer: What's New?(Review) (Disease/Disorder Overview)
Chemoprevention in Bladder Cancer: What's New?(Review) (Disease/Disorder Overview)
2009
Commercial Renal Transplantation: A Risky Venture? A Single Canadian Centre Experience (Original Research) (Report) Commercial Renal Transplantation: A Risky Venture? A Single Canadian Centre Experience (Original Research) (Report)
Commercial Renal Transplantation: A Risky Venture? A Single Canadian Centre Experience (Original Research) (Report)
2011